| MedIntelliBase® NewsTips |
|
|
|
May/June 2007 |
Your
monthly newsletter from the
"better way to access market intelligence" people at medintellibase.com
|
Table
of
Contents
| 1)
Science, Innovation, Synergy - SIS 2007 Conference in Seattle |
- SIS 2007 - A Course in Cardiac, Vascular, and Neurovascular Therapeutics
& Emerging Technology Symposium
|
| 2) "SONOMA" study now joins
"CABERNET" |
- SONOMA -
NexStent Carotid Stent System and FilterWire EZ Embolic Protection
System
|
| 3) MedIntelliBase SMArt
Stats |
- MIB SMArt Stats -
Customized procedure data based on CPT and ICD-9 code maps
|
| 4)
Link
of the Month |
|
| 5) Fun Fact of the Month |
|
| 6) A
Better Way...to Access Market Intelligence |
|
| 7) SidePinch® Clamps
(SPCs) |
- SidePinch Clamps -
Simple, innovative, incredibly useful - in demand by doctors, nurses,
and techs needing easy fluid flow control
|
| 8)
More
Information Available at www.MedIntelliBase.com |
|
| Return
to Top |
|
1) Science, Innovation,
Synergy - SIS 2007 Conference in Seattle
A Course in
Cardiac,
Vascular, and Neurovascular Therapeutics & Emerging Technology
Symposium
Look for several special MIB
NewsTips issues over the next few weeks
describing the upcoming SIS 2007 conference, August
1-4.
This combined comprehensive course and emerging technology symposium is
directed by opinion leaders in vascular medicine and is intended for
those medical professionals and industry experts
with a clinical or technical interest in interventional medicine.
 |
|
Visit the SIS
conference site for more information by clicking the SIS 2007 logo. We
hope to see you in Seattle at SIS 2007! |
Return
to Top
|
2) "SONOMA" now joins
"CABERNET"
Boston Scientific Corporation
has announced the "Post-Market Approval Study of the
NextStent Carotid Stent System and the FilterWire EZ Embolic Protection
System." This "SONOMA" Post-Market
Approval study, a multi-center, U.S. surveillance registry, enrolled
the first of 1,650 patients on May 31, 2007. One hundred sites are
planned with scheduled closure of the registry in September 2009. The
study will confirm the safety of the NexStent Carotid Stent System and
FilterWire EZ Embolic Protection System used in daily clinical practice
for the approved indications.
To review a detailed overview of the
study as depicted below in a SMArt Trial Summary at MedIntelliBase.com, go to "SONOMA"
study.
Subbarao Myla, M.D., Medical Director of Cardiovascular Research and
Vascular Intervention, Hoag Heart and Vascular Institute, Hoag Memorial
Hospital Presbyterian Newport Beach, CA, the principal investigator for
SONOMA, enrolled the first patient. In the BSCI
press release issued June 1, Dr. Myla was quoted
as saying
"We are hopeful that the unique design and other features of the
NexStent Carotid Stent and FilterWire EZ Embolic Protection System will
facilitate a high procedure success rate and relatively low risk of
major disabling stroke or death in a cohort of patients with
symptomatic and asymptomatic carotid artery stenosis that are at high
risk for surgery." A 500-patient cohort will be included to allow an
independent core lab to review analyze patient success based on routine
duplex ultrasound evaluations.
The "CABERNET" Multi-center Trial
["Carotid Artery Revascularization Using the Boston
Scientific EPI FilterWiRe EX and the Endotex NExStenT"]
results supported the FDA’s October 27, 2006 PMA approval of
both devices. Published September 23, 2005, the CABERNET trail was
designed for 600 patients and concluded with 454 patients enrolled,
with 438 showing a stroke rate of 1.3 percent, and a combined stroke,
death, and MI rate of 3.9 percent. To review the final trial results in a SMArt Trial Summary at MedIntelliBase.com, go to "CABERNET".
These SMArt
Trial summaries and over 800 others are
available to subscribers to MedIntelliBase MarketTracks databases. Contact
us to access specific and/or customized clinical trial and
registry summaries
of interest to you.
Interested
in
keeping up to
date on this issue? Is there another area of interest where
you need current, timely clinical research or technology development
information? Click
here to learn more about our MIB
Alerts - A Better Way...to
stay up to date.
Return
to Top
|
3)
MedIntelliBase SMArt Stats - Custom U.S. Healthcare Procedure Data
Announcing a new service! The Next Phase Publishing is pleased and excited to announce its newest offering, MIB
SMArt Stats.
MIB SMArt Stats offer users customized U.S. procedure data based on the American
Medical Association's Current Procedural Technology (CPT) and
International Classification of Diseases (ICD-9) coding systems.
Utilizing data sets available from U.S. governmental sources
including the Centers for Medicare & Medicaid Services (CMS)
and
the Agency for Healthcare Research and Quality (AHRQ), procedure
volumes and associated charge
data are now easy and quick for you to access. For any and all CPT codes that
you need by year, MIB
SMArt Stats reports can take you to the
state and municipal area levels of granularity. Up to 20 additional, directly
associated data fields are available providing details on carriers and
physicians for each procedure.
Until now, the process has been complex. If you venture into this alone
it can consume hundreds of hours of your team's valuable time and
innumerable resources to generate accurate and usable data tables and
reports. MIB
SMArt Stats changes all of this and provides all data for you, quickly, easily, and accurately. If
you have any questions about MIB
SMArt Stats or would like further information about our
customized service, go to MIB
SMArt Stats Info Request form or contact
us directly.
Is there another area of interest where
you need current, timely clinical research or technology development
information? Click
here to learn more about our MIB
Alerts - A Better Way...to
stay up to date.
Return
to Top
|
4) Link
of the Month
- Calcium & Vitamin D may not reduce
risk of heart disease or stroke - A study
recently published in
Circulation, the journal
of the American Heart Association, suggests that over seven years of
use calcium and vitamin D
supplements do not affect the risk of heart disease or stroke
in
generally healthy postmenopausal women. [www.sciencedaily.com]
Return
to Top
|
5) Fun Fact of the Month
- Is a good "belly laugh" good for your heart?-
Dr. Michael Miller of the University of Maryland School of Medicine in
Baltimore and colleagues have demonstrated
for the first time that laughter is linked to healthy function of blood
vessels. Laughter appears to cause the tissue that forms the inner
lining of blood vessels, the endothelium, to dilate or expand in order
to increase blood flow. [www.unm.edu]
Return
to Top
|
6)
MedIntelliBase Custom Email
Alerts now give you A
Better Way
Coming in July - MedIntelliBase Custom Email Alerts with newly updated capabilities including Full-Featured Search. Search any or all
of these databases customized to your area of interest:
- Abstracts
Library
- Alerts
Library
- Full Text
Article Library
- MarketTracks...detailed SMArt Summaries™ on
breaking
clinical trials & registries, and emerging technologies.
Click the image above to view
sample MIB Custom Email Alert formats - a "FullView" Alert, or one of
the
"QuickView" formats --> Lean Alert or UltraLean Alert.
A Better Way
Does
this "quest for Market
Intelligence" sound familiar?
- Search
for market, clinical, or technology "intelligence"
- Agonize
over the high prices
- "Bite
the bullet" and purchase an email alert service
- Sort
through reams of semi-useful results with every alert
- Marvel
at the lack of precise targeting and time you spend using your human
intelligence to screen-out bad
results
- Give
up and spend
hours trying to find the latest developments on Medline or Google
- Search
for hours to find that one abstract or press release from 3 or
4
months ago that supports your point
- Get
frustrated at the inability to find what you need
- Write
your report or your business plan that you know should be better, more
in depth and more precise...if only you had better information
- Vow
that next time, you’ll find a better
way
MedIntelliBase
Alerts now powered by
- WebGUI
search capabilities
- MarketTracks databases
give
you just that...A Better
Way to stay updated on the industry developments important to you.
MIB
Alerts
MedIntelliBase
Custom Email Alerts are highly
flexible,
customized intelligent search filters powered by "Human
Intelligence™" that give you convenient, timely,
and tightly focused updates on new developments in your industry
segment. MIB
Alerts are especially suitable for busy Marketing,
Business Development, and General Management executives in medical
device and biotechnology companies.
Convenient
and Timely
- Respond
to new developments in real time, not weeks or months later
- Keep
you up-to-date on relevant industry events and announcements as they
occur
- Pushed
to you via email, no need to login for news
Easy
to use
- MIB
Alerts do the work for you. You become the "industry expert" in your
organization
- Easy-to-read
and navigate Alerts and
archives
- Fully-searchable
online libraries of abstracts, articles, Alerts, clinical
trial and technology summaries - you choose and customize to your exact
requirements
- Easy-to-search
libraries of abstracts, Alerts or articles that return
documents quickly, within your first query
- Accessible
from anywhere, from Outlook or any web browser
Customized
and Tightly Focused
- Save
you time and make you more effective
- You
receive only those specific developments that matter to you
- You
don't receive useless filler and irrelevant search hits - MIB's "Human Intelligence"
removes the fluff
A few examples of thousands of possibilities
for Alert topics:
Cardiac,
Cardiovascular and Vascular
- Peripheral Arterial
Occlusion (PAO)-
Thrombolysis
- Cardiac Structural
Defects
- Lower Limb PAD &
Atherectomy
- PV Angiography -
Infusion Catheters
- CV/PV Angiography -
Power Injectors
- Deep Vein Thrombosis
(DVT) -
Thrombolysis
Neurology
- Neurostimulation -
Hearing Loss
- Neurostimulation -
Alzheimer's
disease
- Neurostimulation -
Parkinson's
disease
- Drugs and Advanced
Therapies -
Parkinson's disease & Essential Tremor
- Neurostimulation -
Epilepsy
- Neurostimulation - Pain Management
Orthopedic
- Spinal Motion
Preservation
- Hip Resurfacing
- Knee Resurfacing
Emergency
Medicine
View a sampling of Custom Email Alerts
Customize your Alerts with the type of information you specify:
- Clinical article abstracts
- Trials and registries results
- Preclinical article abstracts
- Industry announcements
- Press releases
- Conference notices & proceedings
- Technology developments
- Patents issued & challenged
- Lawsuits & other legal issues
- FDA & voluntary product recalls
- And more
Other custom consulting options:
- Tracking of established and emerging technologies,
landmark and breaking trials and
competing companies
- Strategic analysis and recommendations
- Market potential assessments
You
get much
greater value from customizable MIB
Alerts than from standard
market reports and search engines. You choose the exact depth and
breadth of intelligence
required, realizing the greatest value for your
market intelligence money.
Interested? Want to know more? Want a trial?
Contact
us for:
- More information
- Real-Time MedIntelliBase
Custom Email Alerts
Tour
Return
to Top
|
7) SidePinch Clamps
SidePinch
Clamps (SPCs) are in demand for easy "on-off" use...
- One hand operation - place, lock, unlock
- Easy on, easy off
- No need to break any connection
- Available in a variety of colors and sizes
- Custom configurations available
SPCs are designed for on-demand fluid flow control in a variety of
clinical, medical, emergency and laboratory settings.
Doctors, nurses, lab technicians
and other medical practitioners require smarter closing, clamping and
contamination-prevention devices which are easy-to-use and a great
value...SidePinch Clamps meet their
needs.
Find out how by visiting www.SidePinchClamp.com |
|
Return
to Top
|
|
8) More
Information Available at www.MedIntelliBase.com
You
can find more in-depth information
about MedIntelliBase
Custom Email Alerts - visit the website at www.MedIntelliBase.com or request
more information on the site.
MedIntelliBase MarketTracks and Alerts will help you find the critical
intelligence you need to make
informed product development and business investment decisions.
Contact MedIntelliBase directly...
Return
to Top
|
FYI:
- MedIntelliBase
NewsTips is free and you are welcome to continue receiving it as long
as you wish. If at any time you wish to cancel just click the Safe
Unsubscribe link below.
- We
will not share your name and e-mail address with anyone.
- Feel
free to share or reproduce the information in this MedIntelliBase
NewsTips e-newsletter (in whole or part) as long as proper mention and
copyright notice is given to MedIntelliBase and The Next Phase
Publishing**.
- If
you are not the original recipient of this newsletter and would like to
receive future issues, just click the Forward link below or drop us a
line.
Editor:
Vicky Hunsicker Sanko
The Next Phase Publishing**
Market Research Analyst: Jordan Zornes
The Next Phase Publishing**
Phone - 425/894-4147
www.MedIntelliBase.com
Toll Free - 800/390-2756
Fax - 866/381-6119
** A division of Next Phase® Consultancy,
Inc.
© The Next Phase® Consultancy, Inc. 2007. All rights
reserved.
Return
to Top |
|
